Intestinal Research

Inflammatory bowel diseases
A glycolipid adjuvant, 7DW8-5, provides a protective effect against colonic inflammation in mice by the recruitment of CD1d-restricted natural killer T cells: Chansu Lee, Sung Noh Hong, Young-Ho Kim; Intest Res. 2020;18(4):402-411. Published online April 8, 2020; DOI: https://doi.org/10.5217/ir.2019.00132
Cited By 1; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Fibrostenotic strictures in Crohn’s disease: Jun Hwan Yoo, Stefan Holubar, Florian Rieder; Intest Res. 2020;18(4):379-401. Published online April 10, 2020; DOI: https://doi.org/10.5217/ir.2019.09148
Cited By 21; Full text PubReader ePub Crossref - TDM PDF

Colitis and Crohn’s Foundation (India) consensus statements on use of 5-aminosalicylic acid in inflammatory bowel disease: Ajit Sood, Vineet Ahuja, Vandana Midha, Saroj Kant Sinha, C. Ganesh Pai, Saurabh Kedia, Varun Mehta, Sawan Bopanna, Philip Abraham, Rupa Banerjee, Shobna Bhatia, Karmabir Chakravartty, Sunil Dadhich, Devendra Desai, Manisha Dwivedi, Bhabhadev Goswami, Kirandeep Kaur, Rajeev Khosla, Ajay Kumar, Ramit Mahajan, S. P. Misra, Kiran Peddi, Shivaram Prasad Singh, Arshdeep Singh; Intest Res. 2020;18(4):355-378. Published online July 13, 2020; DOI: https://doi.org/10.5217/ir.2019.09176
Cited By 6; Full text PubReader ePub Crossref - TDM PDF

Clinical management for small bowel of Crohn’s disease in the treat-to-target era: now is the time to optimize treatment based on the dominant lesion: Kenji Watanabe; Intest Res. 2020;18(4):347-354. Published online October 26, 2020; DOI: https://doi.org/10.5217/ir.2020.00032
Cited By 14; Full text PubReader ePub Crossref - TDM PDF

The first step to unveil the epidemiology of inflammatory bowel disease in Central Asia: Seung Wook Hong, Byong Duk Ye; Intest Res. 2020;18(4):345-346. Published online October 26, 2020; DOI: https://doi.org/10.5217/ir.2020.00121
Cited By 5; Full text PubReader ePub Crossref - TDM PDF

Corrigendum: Randomized, crossover questionnaire survey of acceptabilities of controlled-release mesalazine tablets and granules in ulcerative colitis patients: Keiji Yagisawa, Taku Kobayashi, Ryo Ozaki, Shinji Okabayashi, Takahiko Toyonaga, Miki Miura, Mari Hayashida, Eiko Saito, Masaru Nakano, Hajime Matsubara, Tadakazu Hisamatsu, Toshifumi Hibi; Intest Res. 2020;18(3):343-344. Published online July 20, 2020; DOI: https://doi.org/10.5217/ir.2018.00078-c1; Full text PubReader ePub Crossref - TDM PDF

Inflammatory bowel diseases
Sausage-like fingers in Crohn’s disease: Akira Hokama, Taiga Miyagi, Yukiko Takeichi, Eriko Uema, Sayuri Takehara, Tetsuya Ohira, Atsushi Iraha, Tetsu Kinjo, Jiro Fujita; Intest Res. 2020;18(3):341-342. Published online May 25, 2020; DOI: https://doi.org/10.5217/ir.2020.00036; Full text PubReader ePub Crossref - TDM PDF

Incidental benefits after fecal microbiota transplant for ulcerative colitis: Ramit Mahajan, Vandana Midha, Arshdeep Singh, Varun Mehta, Yogesh Gupta, Kirandeep Kaur, Ritu Sudhakar, Anmol Singh Pannu, Dharmatma Singh, Ajit Sood; Intest Res. 2020;18(3):337-340. Published online April 22, 2020; DOI: https://doi.org/10.5217/ir.2019.00108
Cited By 3; Full text PubReader ePub Crossref - TDM PDF

Miscellaneous
Melatonin in the colon modulates intestinal microbiota in response to stress and sleep deprivation: Young Sook Park, Soo Hyung Kim, Jong Won Park, Younglim Kho, Pu Rum Seok, Jae-Ho Shin, Yoon Ji Choi, Jin-Hyun Jun, Hee Chan Jung, Eun Kyung Kim; Intest Res. 2020;18(3):325-336. Published online June 23, 2020; DOI: https://doi.org/10.5217/ir.2019.00093
Cited By 11; Full text PubReader ePub Crossref - TDM PDF

Colorectal tumors
Factors associated with the survival of colorectal cancer in Mexico: Carlos Quezada-Gutiérrez, María Teresa Álvarez-Bañuelos, Jaime Morales-Romero, Clara Luz Sampieri, Raúl Enrique Guzmán-García, Evangelina Montes-Villaseñor; Intest Res. 2020;18(3):315-324. Published online May 19, 2020; DOI: https://doi.org/10.5217/ir.2019.09179
Cited By 2; Full text PubReader ePub Crossref - TDM PDF

Inflammatory bowel diseases
Concordance between tuberculin skin test and interferon-gamma release assay for latent tuberculosis screening in inflammatory bowel disease: Saad Alrajhi, Pascale Germain, Myriam Martel, Peter Lakatos, Talat Bessissow, Talal Al-Taweel, Waqqas Afif; Intest Res. 2020;18(3):306-314. Published online March 20, 2020; DOI: https://doi.org/10.5217/ir.2019.00116
Cited By 6; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Hypermethylated promoters of tumor suppressor genes were identified in Crohn’s disease patients: Tae-Oh Kim, Yu Kyeong Han, Joo Mi Yi; Intest Res. 2020;18(3):297-305. Published online February 7, 2020; DOI: https://doi.org/10.5217/ir.2019.00105
Cited By 5; Full text PubReader ePub Crossref - TDM PDF

Presentation and outcomes among inflammatory bowel disease patients with concurrent pneumatosis intestinalis: a case series and systematic review: Youran Gao, Meka Uffenheimer, Michael Ashamallah, Gregory Grimaldi, Arun Swaminath, Keith Sultan; Intest Res. 2020;18(3):289-296. Published online November 4, 2019; DOI: https://doi.org/10.5217/ir.2019.00073
Cited By 2; Full text PubReader ePub Crossref - TDM PDF

Safety of tumor necrosis factor inhibitor use in patients with concomitant malignancy: Hiep Phan, Rick A. Weideman, Daisha J. Cipher, Linda A. Feagins; Intest Res. 2020;18(3):282-288. Published online April 7, 2020; DOI: https://doi.org/10.5217/ir.2019.09140
Cited By 3; Full text PubReader ePub Crossref - TDM PDF

NUDT15 gene variants and thiopurine-induced leukopenia in patients with inflammatory bowel disease: Katsuyoshi Matsuoka; Intest Res. 2020;18(3):275-281. Published online June 3, 2020; DOI: https://doi.org/10.5217/ir.2020.00002
Cited By 12; Full text PubReader ePub Crossref - TDM PDF

Article category